With such debilitating symptoms, the need for research and patient support for inflammatory bowel conditions is crucial.
The Hospital Research Foundation Group is proud to partner with BiomeBank, which is a world-leader in treating and preventing diseases by replenishing gut microbial ecology.
Inflammatory Bowel Disease Support
Supporting BiomeBank in facilitating safe faecal microbiota transplantation (FMT) for people suffering from clostridium difficile (C-diff) infection and ulcerative colitis, replenishing their healthy gut bacteria and substantially improving their symptoms and quality of life.
Investigating diet strategies to help reduce harmful gut bacteria and reduce inflammation in ulcerative colitis.
Running a clinical trial to investigate whether faecal microbiota transplantation (FMT) can help improve the gut health of people living with Parkinson’s and ease symptoms such as constipation.
Implementing a new software program at the Royal Adelaide Hospital to support the day-to-day management of patients’ inflammatory bowel conditions.